Rutgers, The State University of New Jersey-New Brunswick
1979 to 1985
Skills
Clinical Development • Clinical Trials • Clinical Monitoring • Sop • Regulatory Affairs • Regulatory Submissions • Medical Writing • Clinical Research • Pharmaceutical Industry • Gcp • Ctms • Cro • Lifesciences • R&D • Edc • Pharmacovigilance • Drug Development • Oncology • Ich Gcp • Therapeutic Areas • Drug Discovery • Biotechnology • Infectious Diseases • Fda • Clinical Data Management • Glp • Life Sciences • Cro Management • Clinical Trial Management System • Standard Operating Procedure • Good Clinical Practice • Research and Development
Industries
Pharmaceuticals
Us Patents
Compositions For The Treatment Of Mammalian Diseases
Michael J. Daley - Yardley PA William D. Steber - Ledgewood NJ Gary J. Furda - Trenton NJ Paul A. Johnston - Langhorne PA Elizabeth R. Oldham - Newtown PA
Assignee:
American Cyanamid Company - Wayne NJ
International Classification:
A61K 4505
US Classification:
424 851
Abstract:
A therapeutic composition which contains a potentiating or safening amount of an aqueous surfactant in combination with a bactericidal agent and/or a biological response modifier is described herein. The disclosure further describes an improved method for treating mastitis by administering the composition to an afflicted mammal. Additionally, the disclosure describes a method for screening suitable formulations for treating infectious diseases.
Method Of Treating Or Preventing Mastitis In Animals With Involuting Mammary Glands By Administering Recombinant Cytokines
Michael J. Daley - Yardley PA Gary J. Furda - Trenton NJ Phillip W. Hayes - Rushland PA
Assignee:
American Cyanamid Company - Wayne NJ
International Classification:
A61K 3702
US Classification:
424 852
Abstract:
Cytokines are useful for the ability to improve the natural defense system of the involuting mammary gland. In addition to the immunopotentiating activity, cytokines accelerate the normal physiology of involution of the mammary gland and thereby afford further protection against new infections of mammals. The involuting mammary gland is very susceptible to infection during the early stages of involution and therefore decreasing the period of highest susceptibility while also improving the natural defense mechanisms is of great advantage over most therapies. Used alone, in various cytokine combinations, or in combination with other therapeutics, cytokines protect the mammary gland and cure existing infections and are particularly useful during cessation of lactation and early reinitiating of lactation.
Resumes
Senior Director, Full Service Outsourcing Delivery
Stiefel, a GSK Company since 2012
Director, Clinical Development
GSK since Jan 2001
Director, Clinical Science & Study Operations
Quintiles Inc. Jun 1992 - Jul 1998
Clinical Monitoring / Manager / Program Manager
American Cyanamid May 1985 - May 1992
Biologist / Dev Operations Specialist
Education:
Rutgers, The State University of New Jersey-New Brunswick 1979 - 1985
Skills:
Clinical Development Clinical Trials Clinical Monitoring Sop Regulatory Affairs Regulatory Submissions Medical Writing Clinical Research Pharmaceutical Industry Gcp Ctms Cro Lifesciences R&D Edc Pharmacovigilance Drug Development Oncology Ich Gcp Therapeutic Areas Drug Discovery Biotechnology Infectious Diseases Fda Clinical Data Management Glp Life Sciences Cro Management Clinical Trial Management System Standard Operating Procedure Good Clinical Practice Research and Development
Youtube
My World Cup Predictions, Soccer in the US, a...
Today's episode of the GaryVee Audio Experience is an awesome conversa...
Duration:
21m 17s
John Williams - Star Wars - The imperial marc...
Duration:
3m 2s
Gary Molander History of the Creative Church
Hear from Gary as we talk about what the early church worship environm...